Sharla Clark
Family Medicine · Pocatello, IDNPI 1093078578
Payments from drug & device makers
Across 118 payments — averaging $17.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$553
- Amgen$339
- Lilly USA, LLC$240
- Merz North America, Inc.$124
- Novo Nordisk$108
- GSK$84
- plus $647 from 26 others
What the payments were for
- Food & beverage$2,08199%
- Education$141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 26 | $553 |
| Amgen | 19 | $339 |
| Lilly USA, LLC | 17 | $240 |
| Merz North America, Inc. | 2 | $124 |
| Novo Nordisk | 7 | $108 |
| GSK | 6 | $84 |
| Boehringer Ingelheim | 3 | $51 |
| AstraZeneca | 4 | $50 |
| Abbott | 2 | $47 |
| Galderma Laboratories, L.p. | 2 | $44 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $43 |
| Biohaven Pharmaceuticals, Inc. | 3 | $40 |
| Therapeuticsmd, Inc. | 2 | $34 |
| Boston Scientific | 2 | $32 |
| Irhythm Technologies, Inc. | 1 | $29 |
| Nevro Corp. | 2 | $27 |
| Pfizer | 2 | $24 |
| Novartis | 1 | $21 |
| Sanofi Pasteur Inc. | 1 | $20 |
| Medtronic | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Exact Sciences | 1 | $15 |
| Corcept Therapeutics | 1 | $15 |
| Tandem Diabetes Care, Inc. | 1 | $15 |
| Grifols USA, LLC | 1 | $15 |
| Dexcom, Inc. | 1 | $15 |
| Astellas Pharma US Inc | 1 | $15 |
| Apria Healthcare LLC | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $11 |
| Sumitomo Pharma America, Inc. | 1 | $4 |
How this compares
$2,095 in reported general payments places this provider in the 80th percentile of 803 family medicine providers in Idaho.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 121 | $127,203 |
| SimponiGolimumab | 12 | $84,695 |
| OzempicSemaglutide | 33 | $41,241 |
| Tresiba Flextouch U-200Insulin Degludec | 17 | $19,473 |
| FarxigaDapagliflozin Propanediol | 13 | $14,212 |
| Xigduo XrDapaglifloz Propaned/Metformin | 11 | $11,753 |
| SynthroidLevothyroxine Sodium | 14 | $1,124 |
| Levothyroxine Sodium | 80 | $743 |
| Duloxetine Hcl | 42 | $725 |
| Potassium Chloride | 25 | $624 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $473 |
| Spironolactone | 11 | $463 |
| Carvedilol | 22 | $432 |
| Pantoprazole Sodium | 22 | $415 |
| Gabapentin | 26 | $346 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $240 | $127,203121 claims |
| Novo NordiskOzempic | $108 | $41,24133 claims |
| AstraZenecaFarxiga | $50 | $14,21213 claims |
| AbbVieSynthroid | $553 | $1,12414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 803 family medicine providers in Idaho.
Other family medicine in Pocatello
- Ronald SolbrigPocatello$62K
- Tyler MayoPocatello$22K
- Amber FrostPocatello$16K
- Brandon WestPocatello$6K
- Chance ChristensenPocatello$6K
- Andrew ThaynePocatello$5K
- Mark TurnerMeridian$40.5M
- David ButukMeridian$15.2M
- Gary SoucieBlackfoot$5.8M
- Brock McConneheyBoise$4.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.